India faces the second highest economic burden due to diabetes of USD 11.4 trillion -- the United States bears the highest costs at USD 16.5 trillion, and China the third at USD 11 trillion, a new study has estimated. Researchers, including those from the International Institute for Applied Systems Analysis and the Vienna University of Economics and Business in Austria, calculated the economic impact of diabetes across 204 countries from 2020 to 2050. Global costs amount to around USD 10 trillion, excluding informal care provided by family members -- about 0.2 per cent of the world's annual gross domestic product (GDP), findings published in the journal Nature Medicine show. Factoring in informal care amounts to up to USD 152 trillion, or 1.7 per cent of the world's yearly GDP, the study estimates. "Caregivers often drop out of the labour market, at least partially, which creates additional economic costs," author Klaus Prettner, professor of macroeconomics and digitalisation at th